ER/PR
Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer.
13
www.ijcep.com /IJCEP1012011 Case Report Invasive pleomorphic lobular carcinoma, negative for ER, PR and Her/2neu - a case report
6
Study of prevalence of prognostic and predictive immunohistochemical markers er, PR and Her2/neu and their correlation with age in cases of female carcinoma breast in Bihar (Northern India)
5
Correlation of Breast Cancer Subtypes Based on ER, PR and HER2 Expression with Axillary Lymph Node Status
7
C-MYC and BCL2 Expression in Normal Tissue Around Proliferative Breast Conditions in Relation to ER, PR in a Sample of Iraqi Women
6
Effect of Modified and accumulated decoction on serum ER, PR, sex hormone, IGF-I and IGF-I in patients with uterine fibroids
5
A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer
12
Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67
7
To Assess the Stromal Expression of CD10 in Invasive Ductal Carcinoma of Breast and It’s Correlation with Histological Grade, ER, PR AND HER2/neu Expression
129
Molecular Subtypes of Ductal Carcinoma In Situ (DCIS) Identified by Expression of ER, PR, HER2, and Ki-67
6
Neurotensin Receptor 1 (NTSR1) Overexpression in Breast Carcinomas Is Common and Independent of ER/PR/Her2 Expression
6
Role of er, pr, her2 and egfr in esophageal carcinoma
6
Prognostic Implications of ER, PR and HER2/Neu Protein Expression in a Cohort of Breast Carcinoma
6
The Effect of Neoadjuvant Chemotherapy on ER, PR and HER 2 Expression in Breast Cancer
13
Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.
15
Original Article Characteristic of ER /PR and Ki67 value with breast cancer
7
Clinico-Pathological Study of Breast Carcinomas with ER, PR Studies.
109
Correlation of ER, PR and Her-2/Neu with Histological Variants of Breast Carcinoma.
69
Does Metformin affect ER, PR, IGF-1R, β-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer?
11
To Study the Immunohistochemical expression of BRCA 1 in breast cancer and to assess its association with expression of ER, PR and HER 2 receptors
112